CDSCO License for External cardiac compressor
Medical Device Information
Intended Use
An external cardiac compressor is an externally applied prescription device that is electrically, pneumatically, or manually powered and is used to compress the chest periodically in the region of the heart to provide blood flow during cardiac arrest. External cardiac compressor devices are used as an adjunct to manual cardiopulmonary resuscitation (CPR) when effective manual CPR is not possible (e.g., during patient transport or extended CPR when fatigue may prohibit the delivery of effective/consistent compressions to the victim, or when insufficient EMS personnel are available to provide effective CPR).

Comprehensive Guide to CDSCO Licensing for External Cardiac Compressors (Class C Medical Device)
Introduction: Understanding External Cardiac Compressors and Regulatory Importance
An external cardiac compressor is a crucial cardiovascular medical device designed to deliver mechanical chest compressions during cardiac arrest. Powered electrically, pneumatically, or manually, this device supports manual cardiopulmonary resuscitation (CPR) by ensuring consistent, effective compressions—especially during patient transport or extended resuscitation efforts where fatigue or insufficient personnel can compromise manual CPR quality.
Given the life-saving nature and complexity of external cardiac compressors, regulatory compliance is paramount. The Central Drugs Standard Control Organization (CDSCO) mandates stringent controls to guarantee safety, efficacy, and quality before market entry in India. As seasoned regulatory consultants with over 25 years of experience and having assisted 500+ companies, we provide you with detailed, practical insights into obtaining the required CDSCO license for your external cardiac compressor.
CDSCO Regulatory Framework for External Cardiac Compressors
External cardiac compressors fall under the Class C risk category according to the Indian Medical Device Rules. This classification reflects the moderate to high risk associated with the device, necessitating a centralized licensing process managed by the CDSCO Central Licensing Authority.
The regulatory framework for Class C devices includes:
- Pre-market testing and certification
- Submission of comprehensive technical documentation
- Compliance with Indian and international Quality Management System (QMS) standards
- Audit and inspection by CDSCO officials
- License issuance under Form MD9
For detailed classification parameters, you can review the Medical Device Classification guide.
Risk Classification and License Requirements for External Cardiac Compressors
- Device Class: Class C (Moderate to high risk)
- License Type: MD9 Manufacturing License (Form MD7)
- Licensing Authority: CDSCO Central Licensing Authority (New Delhi)
Class C devices such as external cardiac compressors require a centralized approval pathway, including rigorous product testing, documentation, and audits.
Manufacturing License Process (MD9) for Class C Devices
The manufacturing license process for Class C devices is comprehensive and typically spans 4 to 5 months. The key steps include:
Test License Application (Form MD13): Initiate by applying for a test license, which allows you to manufacture samples for testing. This phase alone takes approximately 1.5 to 2 months.
Product Testing: Conduct mandatory product testing in CDSCO-approved laboratories. This is crucial for verifying compliance with essential principles and safety standards. Find the list of Testing Laboratories here.
Documentation Preparation: Prepare extensive documentation including Device Master File, Plant Master File, Risk Management File, Essential Principles Checklist, and QMS documents.
Manufacturing License Application (Form MD7): Submit your complete application through the CDSCO MD Online Portal.
CDSCO Audit and Inspection: An on-site audit by CDSCO inspectors evaluates your manufacturing facility's compliance.
Query Resolution: Promptly address any queries or deficiencies raised by the department or auditors.
License Grant (Form MD9): Upon successful completion of all steps, the MD9 license is granted.
For a detailed stepwise explanation, our MD9 License Guide is an invaluable resource.
Manufacturing License Documents Required for External Cardiac Compressors
To avoid delays, ensure your submission includes the following critical documents:
- Company Constitution Documents (e.g., Certificate of Incorporation)
- Proof of Ownership or Lease of Manufacturing Premises
- Technical Staff Qualification and Experience Records
- Valid Fire NOC and Pollution Control NOC
- Device Master File (DMF): Detailed design and manufacturing process documentation. Learn more from our Device Master File guide.
- Plant Master File (PMF): Describes the manufacturing facility, equipment, and processes. Refer to our Plant Master File guide.
- Essential Principles Checklist: Compliance checklist aligned with CDSCO guidelines.
- Risk Management File: Documentation showing risk analysis and mitigation strategies for the device, critical for cardiovascular devices. For best practices, see our Risk Management guide.
- Test Reports: Results from government-approved laboratories.
- Labels and Instructions for Use (IFU): Clearly indicating intended use, safety instructions, and manufacturer details.
- Quality Management System Documents: Evidence of ISO 13485:2016 certification activities and internal audit reports.
Import License Process (MD15) for External Cardiac Compressors
If you are an importer seeking to bring external cardiac compressors into India, you must obtain an MD15 Import License from the CDSCO Central Licensing Authority. The process typically takes 5 to 6 months and involves:
Document Preparation: Compile a dossier including manufacturing licenses, Free Sale Certificate (FSC), ISO 13485:2016, CE Certificate (if applicable), Device and Plant Master Files, and wholesale licenses.
Application Submission: File the application on the CDSCO MD Online Portal using Form MD14.
Query Resolution: Respond promptly to any department queries.
License Issuance: Upon satisfaction, the MD15 license is granted.
The detailed steps and document checklist are covered comprehensively in our Import License Guide.
Import License Documents Required
- Manufacturing License of the foreign manufacturer
- Free Sale Certificate from country of origin
- ISO 13485:2016 certification
- CE Certificate or equivalent international approvals
- Device Master File and Plant Master File
- Wholesale License for import
- Company Constitution Documents
Timeline and Processing Duration
License Type | Approximate Duration | Key Milestones |
---|---|---|
Test License (MD13) | 1.5 - 2 months | Sample manufacturing and testing start |
Manufacturing License (MD9) | 4 - 5 months | Application, audit, query resolution, license grant |
Import License (MD15) | 5 - 6 months | Document evaluation, query resolution, license grant |
Understanding these timelines helps manufacturers and importers plan their market entry strategies efficiently.
Government Fees and Costs
For Class C external cardiac compressors, the fee structure is as follows:
MD9 Manufacturing License:
- Application fee: ₹50,000
- Per product fee: ₹1,000
MD13 Test License:
- Standard fees as applicable (varies with device and testing requirements)
MD15 Import License:
- Application fee per site: $3,000
- Per product fee: $1,500
These fees are payable via the CDSCO portal during application submission.
Common Challenges and Solutions
Challenge 1: Delays in obtaining timely product test reports.
Solution: Engage with CDSCO-approved laboratories early in the process. Refer to the official Testing Laboratories list and plan testing schedules proactively.
Challenge 2: Incomplete or inconsistent documentation leading to repeated queries.
Solution: Utilize expert consultants to prepare meticulous Device and Plant Master Files. Our comprehensive guides on Device Master Files and Plant Master Files can streamline this.
Challenge 3: Non-compliance with Essential Principles or QMS gaps.
Solution: Implement a robust risk management framework, and ensure ISO 13485:2016 QMS readiness. Our Risk Management guide provides actionable insights.
Challenge 4: Audit non-conformities during CDSCO inspection.
Solution: Conduct pre-audit internal assessments and engage notified bodies listed in the Notified Bodies List for MD5 Audit for advisory audits even though MD9 audits are by CDSCO.
Expert Consultation and Support
Navigating CDSCO licensing for Class C devices like external cardiac compressors requires expertise and experience. Our team has supported over 500 manufacturers and importers to achieve timely approvals by:
- Preparing tailored documentation packages
- Coordinating with testing laboratories and notified bodies
- Managing audit readiness and query responses
- Providing end-to-end application submission and follow-up
Partnering with experienced consultants significantly reduces regulatory risks and accelerates market entry.
Getting Started with Your CDSCO License Application for External Cardiac Compressors
To initiate your licensing journey:
- Classify your device accurately as Class C and confirm CDSCO requirements.
- Register on the CDSCO MD Online Portal to access application forms and submit documents electronically.
- Apply for the Test License (Form MD13) to begin manufacture of samples for testing.
- Engage CDSCO-approved testing laboratories early to schedule product testing.
- Prepare your Device Master File, Plant Master File, Risk Management File, and QMS documentation with expert assistance.
- Submit your Manufacturing License application (Form MD7) upon successful testing.
- Coordinate with CDSCO for audits and promptly address queries.
Starting early and following a well-defined plan is critical for success. For personalized assistance, contact us to leverage our 25+ years of regulatory expertise in India’s medical device landscape.
Embarking on the CDSCO licensing process for your external cardiac compressor is a strategic investment in compliance and market access. With the right guidance, you can confidently navigate the regulatory pathway and bring this life-saving cardiovascular device to the Indian healthcare ecosystem.